The newly CE-Marked Paige Prostate solution detects cancerous areas and enables pathologists to find these cancerous areas quickly, prospectively improving diagnostic quality and pathologist efficiency in the review of these cases. Additionally, the software can be used for real-time quality review of cases to identify diagnostic discrepancies and thus boost overall quality for a practice.
In a usability study leveraging Paige Prostate and the Insight viewer, Paige found that the technology proved most impactful in the detection of small, well-differentiated foci of cancer, many of which were missed by multiple pathologists. These lesions are difficult to detect and often require further studies at additional expense, such as immunohistochemistry or second opinions.
Ad Statistics
Times Displayed: 60652
Times Visited: 1936 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Paige is excited to announce that with this CE Mark, these first two Paige solutions are ready to be deployed and used in European laboratories and hospitals.
About Paige
Based in New York City, Paige was founded in 2017 to serve doctors and patients by revolutionizing cancer diagnosis and treatment with new AI-based technologies that combine pathology, genomics and outcomes data. The company received the first FDA breakthrough designation for an oncology diagnostic and is actively developing several other diagnostic and prognostic products.
SOURCE Paige
Back to HCB News
